MedMira Valuation
| 47M Stock | EUR 0.07 0 3.82% |
MedMira seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of MedMira from analyzing the firm fundamentals such as Operating Margin of (1.79) %, return on asset of -0.23, and Shares Outstanding of 697.45 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that MedMira's price fluctuation is out of control at this time. Calculation of the real value of MedMira is based on 3 months time horizon. Increasing MedMira's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MedMira stock is determined by what a typical buyer is willing to pay for full or partial control of MedMira. Since MedMira is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MedMira Stock. However, MedMira's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.068 | Real 0.0539 | Hype 0.07 | Naive 0.0665 |
The real value of MedMira Stock, also known as its intrinsic value, is the underlying worth of MedMira Company, which is reflected in its stock price. It is based on MedMira's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MedMira's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MedMira helps investors to forecast how MedMira stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MedMira more accurately as focusing exclusively on MedMira's fundamentals will not take into account other important factors: MedMira Total Value Analysis
MedMira is presently estimated to have takeover price of 34.88 M with market capitalization of 62.47 M, debt of 40 K, and cash on hands of 20.61 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MedMira fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
34.88 M | 62.47 M | 40 K | 20.61 K |
MedMira Investor Information
About 70.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the key measurements obtained from MedMira's financial statements, MedMira is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.MedMira Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MedMira has an asset utilization ratio of 24.86 percent. This implies that the Company is making €0.25 for each dollar of assets. An increasing asset utilization means that MedMira is more efficient with each dollar of assets it utilizes for everyday operations.MedMira Ownership Allocation
MedMira maintains a total of 697.45 Million outstanding shares. MedMira secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.39 % of MedMira outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.MedMira Profitability Analysis
The company reported the revenue of 952.13 K. Net Loss for the year was (1.83 M) with loss before overhead, payroll, taxes, and interest of (512.51 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MedMira's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MedMira and how it compares across the competition.
About MedMira Valuation
The stock valuation mechanism determines MedMira's current worth on a weekly basis. Our valuation model uses a comparative analysis of MedMira. We calculate exposure to MedMira's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MedMira's related companies.MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. MEDMIRA INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.
8 Steps to conduct MedMira's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates MedMira's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MedMira's valuation analysis, follow these 8 steps:- Gather financial information: Obtain MedMira's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine MedMira's revenue streams: Identify MedMira's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research MedMira's industry and market trends, including the size of the market, growth rate, and competition.
- Establish MedMira's growth potential: Evaluate MedMira's management, business model, and growth potential.
- Determine MedMira's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MedMira's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for MedMira Stock analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |